Belgium emerges as preferred European R&D hub for pharma firms on tax incentives

Thiruvananthapuram, Nov 12 (UNI) Belgium is emerging as a preferred destination among European union countries for pharmaceutical companies to establish research and development (R&D) facilities, with tax incentives bringing the effective corporate tax rate down to as low as 3.75 per cent for R&D investments, experts from Belgium said here on Thursday. The country's favourable tax regime, strong research ecosystem, strategic location and access to European markets make it an attractive destination for Indian startups and businesses looking to expand their operations in Europe, they said at a panel discussion on 'Belgium as a gateway to Europe for Indian startups'…